Rendering of Lilly's forthcoming manufacturing site in Alzey, Germany (Credit: Eli Lilly)

November 17, 2023 10:29 AM EST

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs

Anna Brown

News Reporter

Kyle LaHucik

Senior Reporter

Eli Lilly is set to build a new $2.5 billion facility in Germany to increase manufacturing capacity for its blockbuster diabetes and obesity drugs, and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs

Anna Brown

News Reporter

Kyle LaHucik

Senior Reporter

Sign up to read this article for free.

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

Surrounded by AI bio giants, tiny startup Nabla Bio makes de novo antibodies look more like drugs

Patient dies in Neurogene's Rett syndrome study

Are programs with compounded GLP-1s safe for your population?

Lil­ly in­vests $2.5B in new Ger­man site to boost tirzepatide sup­ply, $100M for lo­cal biotechs

News Reporter

Senior Reporter

Sign up to read this article for free.

Lilly invests $2.5B in new German site to boost tirzepatide supply, $100M for local biotechs